• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血因子V的A1结构域中的Asp68His突变导致分泌受损和转运无效。

Asp68His mutation in the A1 domain of human factor V causes impaired secretion and ineffective translocation.

作者信息

Liu H C, Shen M C, Eng H L, Wang C H, Lin T M

机构信息

Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan; Department of Medical Research, E-DA Hospital/I-SHOU University, Kaohsiung, Taiwan.

出版信息

Haemophilia. 2014 Jul;20(4):e318-26. doi: 10.1111/hae.12476. Epub 2014 Jun 3.

DOI:10.1111/hae.12476
PMID:24893683
Abstract

Congenital factor V (FV) deficiency is a rare inherited disorder. We determined the mechanism of a missense mutation, Asp68His, in the A1 domain of the FV protein, is associated with severe FV deficiency. We characterized the mutant FV-Asp68His protein using in vitro expression studies by using specific secretion and degradation pathway inhibitors and analysed the intracellular translocation of the mutant protein by immunofluorescence staining. The Asp68His mutation caused very low levels of FV protein in the conditioned media, with normal specific FV activity. Similar mRNA degradation rates between FV-wild-type (wt) and FV-Asp68His mRNA showed that the Asp68His mutation does not affect FV expression at the transcriptional level. A specific secretion pathway inhibitor, brefeldin A, was used to demonstrate that the lower efficiency of transport to the outside of the cell for FV-Asp68His mutant protein compared with that of the FV-wt protein. Furthermore, we showed that the Asp68His mutation resulted in increased intracellular degradation through a MG132-mediated proteasomal degradation pathway. In the transfected cell lysates, FV-wt protein had multiple posttranslational modified forms, but the FV-Asp68His protein was not completely glycosylated. We further observed that the FV-Asp68His protein was retrieved in the endoplasmic reticulum only and did not undergo transport to the Golgi apparatus, leading to impaired secretion. These results strongly suggest that the Asp68His mutation may result in intracellular defective trafficking and enhanced degradation, and impaired secretion of FV protein.

摘要

先天性因子V(FV)缺乏症是一种罕见的遗传性疾病。我们确定了FV蛋白A1结构域中的一个错义突变Asp68His与严重FV缺乏症相关的机制。我们通过使用特异性分泌和降解途径抑制剂进行体外表达研究来表征突变型FV-Asp68His蛋白,并通过免疫荧光染色分析突变蛋白的细胞内转运。Asp68His突变导致条件培养基中FV蛋白水平极低,但FV特异性活性正常。FV野生型(wt)和FV-Asp68His mRNA之间相似的mRNA降解率表明,Asp68His突变在转录水平上不影响FV表达。使用一种特异性分泌途径抑制剂布雷菲德菌素A来证明,与FV-wt蛋白相比,FV-Asp68His突变蛋白转运到细胞外的效率较低。此外,我们表明Asp68His突变通过MG132介导的蛋白酶体降解途径导致细胞内降解增加。在转染的细胞裂解物中,FV-wt蛋白有多种翻译后修饰形式,但FV-Asp68His蛋白未完全糖基化。我们进一步观察到,FV-Asp68His蛋白仅在内质网中被回收,未转运至高尔基体,导致分泌受损。这些结果强烈表明,Asp68His突变可能导致FV蛋白细胞内运输缺陷、降解增强和分泌受损。

相似文献

1
Asp68His mutation in the A1 domain of human factor V causes impaired secretion and ineffective translocation.人凝血因子V的A1结构域中的Asp68His突变导致分泌受损和转运无效。
Haemophilia. 2014 Jul;20(4):e318-26. doi: 10.1111/hae.12476. Epub 2014 Jun 3.
2
Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency.FV蛋白A1结构域中导致II型缺陷的新型错义突变His147Arg的功能特性分析
Thromb Res. 2014 Jul;134(1):153-9. doi: 10.1016/j.thromres.2014.04.005. Epub 2014 Apr 13.
3
A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene.一例因凝血因子V基因复合杂合突变导致的凝血因子V缺乏症。
Haemophilia. 2006 Mar;12(2):172-8. doi: 10.1111/j.1365-2516.2006.01206.x.
4
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
Blood. 2002 Oct 1;100(7):2515-21. doi: 10.1182/blood.V100.7.2515.
5
Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.凝血因子V的C2结构域中Arg2074Cys错义突变导致中度严重的凝血因子V缺乏:通过重组蛋白表达进行分子特征分析
Blood. 2003 Jan 1;101(1):173-7. doi: 10.1182/blood-2002-06-1928. Epub 2002 Aug 15.
6
Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain.严重的因子V缺乏症:因子V基因中的外显子跳跃导致C1结构域部分缺失。
J Thromb Haemost. 2003 Jun;1(6):1237-44. doi: 10.1046/j.1538-7836.2003.00160.x.
7
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.导致因子V缺乏的三种新型剪接突变的分子特征及F5基因剪接模式分析
Haematologica. 2008 Oct;93(10):1505-13. doi: 10.3324/haematol.12934. Epub 2008 Aug 25.
8
Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency.鉴定一名受严重凝血因子 V 缺乏症影响的土耳其患者中新型错义突变的功能特征。
Haemophilia. 2012 Mar;18(2):205-10. doi: 10.1111/j.1365-2516.2011.02621.x. Epub 2011 Jul 21.
9
Ser234Leu missense mutation in the A1 domain of factor V causing moderate factor V deficiency in a Chinese family.A1 结构域因子 V Ser234Leu 错义突变导致中国一个家系中出现中度因子 V 缺乏。
Pathology. 2009;41(6):566-71. doi: 10.1080/00313020903072734.
10
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.R1698W 域间突变导致凝血因子 V 缺乏症的分子基础。
Thromb Haemost. 2013 Jul;110(1):31-8. doi: 10.1160/TH12-10-0780. Epub 2013 Apr 25.

引用本文的文献

1
Factor V variants in bleeding and thrombosis.出血和血栓形成中的凝血因子V变体
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan.
2
A Novel Phenotype of the Factor 5 Gene Mutation (Homozygote Met1736Val and Heterozygote Asp68His) Is Associated With Moderate Factor V Deficiency.因子Ⅴ基因突变(纯合子Met1736Val和杂合子Asp68His)的一种新表型与中度因子Ⅴ缺乏相关。
Front Med (Lausanne). 2022 Jun 9;9:870269. doi: 10.3389/fmed.2022.870269. eCollection 2022.
3
High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies.
高突变异质性,以及人类凝血因子 V 基因中的新突变。使用重组和先进疗法治疗因子 V 缺乏症的未来展望。
Int J Mol Sci. 2021 Sep 8;22(18):9705. doi: 10.3390/ijms22189705.
4
[Analysis of a pedigree with inherited factor V deficiency caused by compound heterozygous mutation].[复合杂合突变导致遗传性因子V缺乏症的家系分析]
Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):135-139. doi: 10.3760/cma.j.issn.0253-2727.2021.02.008.
5
Congenital factor V deficiency from compound heterozygous mutations with a novel variant c.2426del (p.Pro809Hisfs*2) in the F5 gene: A case report.F5基因复合杂合突变伴新变异c.2426del(p.Pro809Hisfs*2)导致的先天性因子V缺乏症:一例报告
Medicine (Baltimore). 2020 Jan;99(5):e18947. doi: 10.1097/MD.0000000000018947.
6
Genetic Confirmation of Congenital Factor V Deficiency in Korean Patients.韩国患者先天性因子V缺乏症的基因确诊
Ann Lab Med. 2016 Mar;36(2):182-4. doi: 10.3343/alm.2016.36.2.182.